[go: up one dir, main page]

TR200003414T2 - Anti-viral compositions - Google Patents

Anti-viral compositions

Info

Publication number
TR200003414T2
TR200003414T2 TR2000/03414T TR200003414T TR200003414T2 TR 200003414 T2 TR200003414 T2 TR 200003414T2 TR 2000/03414 T TR2000/03414 T TR 2000/03414T TR 200003414 T TR200003414 T TR 200003414T TR 200003414 T2 TR200003414 T2 TR 200003414T2
Authority
TR
Turkey
Prior art keywords
viruses
viral compositions
virus
picona
coxaci
Prior art date
Application number
TR2000/03414T
Other languages
Turkish (tr)
Inventor
Ezquerra-Carrera Jesus
Michael Gruber Joseph
Hamdouchi Hamdouchi Chaf�G
Elmer Holmes Richard
Alfred Spitzer Wayne
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200003414T2 publication Critical patent/TR200003414T2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)

Abstract

Söz konusu bulus pikorna virüslerin, Hepatit virüslerinin, bagirsak virüslerinin, kardiyo virüslerin, polyo virüslerin, A ve B gruplarinin koksaki virüslerinin, eko virüsün ve mengo virüsün çogalmasini engelleyen Formül (I)'e uygun terkipler ve bunun farmasötik olarak kabul edilir tuzlari ile ilgilidir.The present invention relates to formulas according to Formula (I) and its pharmaceutically acceptable salts which prevent the reproduction of picona viruses, Hepatitis viruses, intestinal viruses, cardio viruses, polio viruses, coxaci viruses of A and B groups, echo virus and mengo virus.

TR2000/03414T 1998-05-20 1998-05-20 Anti-viral compositions TR200003414T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/010299 WO1999059587A1 (en) 1998-05-20 1998-05-20 Anti-viral compounds

Publications (1)

Publication Number Publication Date
TR200003414T2 true TR200003414T2 (en) 2001-03-21

Family

ID=22267098

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03414T TR200003414T2 (en) 1998-05-20 1998-05-20 Anti-viral compositions

Country Status (15)

Country Link
EP (1) EP1077701A4 (en)
JP (1) JP2002515433A (en)
KR (1) KR20010025055A (en)
CN (1) CN1292697A (en)
AU (1) AU7583098A (en)
BR (1) BR9815899A (en)
CA (1) CA2332403A1 (en)
CZ (1) CZ289425B6 (en)
EA (1) EA200001208A1 (en)
HU (1) HUP0102117A2 (en)
IL (1) IL139166A0 (en)
NO (1) NO20005795L (en)
SK (1) SK17482000A3 (en)
TR (1) TR200003414T2 (en)
WO (1) WO1999059587A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR213700A0 (en) 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
AR048650A1 (en) * 2004-05-04 2006-05-10 Tibotec Pharm Ltd DERIVATIVES OF (1,10B-DIHIDRO-2- (AMINOCARBONIL-PHENYL) -5H-PIRAZOLO [1,5 C] [1,3] BENZOXAZIN-5-IL) METHANONE PHENYL AS INHIBITORS OF HIV VIRAL REPLICATION
US7544702B2 (en) 2004-08-12 2009-06-09 Amgen Inc. Bisaryl-sulfonamides
MX2007011710A (en) * 2005-03-21 2007-11-20 S Bio Pte Ltd Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications.
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
ATE475660T1 (en) 2005-12-21 2010-08-15 Abbott Lab ANTIVIRAL COMPOUNDS
WO2007081517A2 (en) 2005-12-21 2007-07-19 Abbott Laboratories Anti-viral compounds
US7910595B2 (en) 2005-12-21 2011-03-22 Abbott Laboratories Anti-viral compounds
EP2094276A4 (en) 2006-12-20 2011-01-05 Abbott Lab Anti-viral compounds
BRPI0912038A2 (en) * 2008-05-27 2017-06-20 Biota Scient Management Pty Ltd compound, mixture, pharmaceutical composition, use of the compound, and methods for treating and preventing picornavirus infection, and for forming the compound
CA2740195A1 (en) 2008-12-23 2010-07-01 Abbott Laboratories Anti-viral compounds
RU2505540C2 (en) 2008-12-23 2014-01-27 Эббви Инк. Antiviral compounds
RU2541571C2 (en) 2009-04-15 2015-02-20 Эббви Инк. Antiviral compounds
WO2014060381A1 (en) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclic compounds as pesticides
WO2014067962A1 (en) 2012-10-31 2014-05-08 Bayer Cropscience Ag Novel heterocyclic compounds as pest control agents
CN104370732B (en) * 2014-01-26 2015-08-19 山东信立泰药业有限公司 The preparation method of a kind of clopidogrel and intermediate thereof
CN109535405B (en) * 2017-09-21 2021-07-30 宁波聚嘉新材料科技有限公司 A kind of preparation method of polyarylate based on 2-(4-carboxyphenyl)-5-hydroxypyridoimidazole
CN109810085B (en) * 2019-04-19 2019-07-19 上海皓元生物医药科技有限公司 The preparation method of ACC inhibitor and its intermediate
CN110746450A (en) * 2019-09-17 2020-02-04 济南康和医药科技有限公司 Synthetic method of beraprost sodium key intermediate
CN117902992A (en) * 2024-01-04 2024-04-19 浙江永太科技股份有限公司 A preparation method of 2,4-difluorophenylglycine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096264A (en) * 1975-12-09 1978-06-20 Merck & Co., Inc. Certain substituted imidazo [1,2-a] pyridines
US4250174A (en) * 1979-05-02 1981-02-10 Merck & Co., Inc. 3-Substituted imidazo [1,2-A] pyridines
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
JP2000511899A (en) * 1996-06-05 2000-09-12 イーライ・リリー・アンド・カンパニー Anti-viral compounds
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds

Also Published As

Publication number Publication date
NO20005795L (en) 2001-01-18
CZ20004278A3 (en) 2001-05-16
WO1999059587A1 (en) 1999-11-25
EP1077701A4 (en) 2002-03-20
NO20005795D0 (en) 2000-11-16
CN1292697A (en) 2001-04-25
EP1077701A1 (en) 2001-02-28
CA2332403A1 (en) 1999-11-25
AU7583098A (en) 1999-12-06
KR20010025055A (en) 2001-03-26
CZ289425B6 (en) 2002-01-16
HUP0102117A2 (en) 2001-12-28
JP2002515433A (en) 2002-05-28
EA200001208A1 (en) 2001-06-25
BR9815899A (en) 2001-02-20
SK17482000A3 (en) 2005-03-04
IL139166A0 (en) 2001-11-25

Similar Documents

Publication Publication Date Title
TR200003414T2 (en) Anti-viral compositions
EA200300023A1 (en) 3'-PROCEDURES 2'-DEOXY-β-L-NUCLEOSIDES
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
TR200300544T1 (en) Molten cyclic compounds and their medical uses
TW200730478A (en) N-(6-membered aromatic ring)-amido anti-viral compounds
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
HUP0101999A2 (en) 4-hydroxyquinoline-3-carboxamides and hydrazides use of them and pharmaceutical compositions containing them
DE69705829D1 (en) META-SUBSTITUTED PHENYLSULPHONAMIDE DERIVATIVES
ATE231149T1 (en) (1,8)-NAPHTHYRIDINE DERIVATIVES DERIVATIVES WITH ANTIVIRAL EFFECT
TW200730476A (en) N-(5-membered aromatic ring)-amido anti-viral compounds
MX2007004783A (en) Inhibitors of hepatitis c virus protease, and compositions and treatments using the same.
EA200100838A1 (en) GKSF CONJUGATES
TR200100438T2 (en) Hepatitis C inhibitor peptides
DE69818094D1 (en) ANTIVIRAL CONNECTIONS
NO954072D0 (en) Water-soluble camptothecin derivatives, processes for their preparation and their use as antitumor agents
EA200100983A1 (en) DERIVATIVES 13-METHYLERITROMYCIN
EP1230925A4 (en) ANTI HIV COMPOSITIONS
DK0915894T3 (en) nucleotide analogs
EA199900163A1 (en) ACRYLOIL-SUBSTITUTED DISTAMICINE DERIVATIVES, METHODS OF THEIR RECEIVING AND THEIR APPLICATION AS ANTI-TUMOR AND ANTI-VIRUS FUNDS
DK1149910T3 (en) Pharmaceutical preparation for treating papillomavirus tumors and infection
EA200000431A2 (en) New substituted dimeric compounds, a process for their preparation and pharmaceutical compositions containing them
OA08358A (en) New derivatives of 2,3-dihydro benzofuran, their preparation processes and the pharmaceutical compositions which contain them.
PT781126E (en) 2-AMINO-1,2,3,4-TETRA-HYDRO-NAFTALINO DERIVATIVES ACTIVE IN THE CARDIOVASCULAR SYSTEM
WO2000040242A3 (en) Preparation of a composition against hepatitis b-, hi-, paramyxo- and orthomyxoviruses
BG102813A (en) New hydroxy- and polyhydroxyderivatives of cumarin, methods for their preparation and their antiviral effect